Literature DB >> 15006706

Functional analysis of connexin-32 mutants associated with X-linked dominant Charcot-Marie-Tooth disease.

Hung-Li Wang1, Wen-Teng Chang, Tu-Hsueh Yeh, Tony Wu, Mei-Shin Chen, Ching-Yi Wu.   

Abstract

To investigate the pathogenic role of connexin-32 (Cx32) mutation in X-linked dominant Charcot-Marie-Tooth disease (CMTX), dual whole-cell voltage-clamp recordings and tracer coupling were performed to investigate functional properties of wild-type and 22 CMTX mutant Cx32 proteins expressed in N2A cells. Ten mutant Cx32 proteins either formed defective junctional channels (Y65C, V95M, R107W, L156R, R164W and G199R) or failed to form gap junctions (G12S, S182T, E208K and Y211stop). Except (G12S) and (E208K) mutants, other mutant Cx32 proteins were localized in the cell membrane despite their impaired ability to form functional gap junctions. Twelve CMTX mutations (V13L, R15Q, R22Q, I30N, V35M, V63I, R75Q, Q80R, W133R, P158A, P172S and N205S) did not affect the ability of Cx32 to form homotypic gap junctions in N2A cells. Our results indicate that 10 of 22 CMTX Cx32 mutations studied in the present investigation could lead to the assembly of defective Cx32 gap junctions, which in turn may result in peripheral neuropathy. However, further studies are required to elucidate the exact mechanism by which CMTX mutant Cx32 proteins, which retain the ability to form homotypic junctional channels, damage Schwann cells and cause demyelinating neuropathy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15006706     DOI: 10.1016/j.nbd.2003.11.005

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  16 in total

1.  Four novel connexin 32 mutations in X-linked Charcot-Marie-Tooth disease with phenotypic variability.

Authors:  G Karadima; M Panas; P Floroskufi; N Kalfakis; D Vassilopoulos
Journal:  J Neurol       Date:  2005-08-17       Impact factor: 4.849

2.  Role of the cytoplasmic loop domain of Cx43 in its intracellular localization and function: possible interaction with cadherin.

Authors:  Chika Nambara; Yumi Kawasaki; Hiroshi Yamasaki
Journal:  J Membr Biol       Date:  2007-07-13       Impact factor: 1.843

Review 3.  Gap junctions in inherited human disease.

Authors:  Georg Zoidl; Rolf Dermietzel
Journal:  Pflugers Arch       Date:  2010-02-07       Impact factor: 3.657

Review 4.  Gap junctions in inherited human disorders of the central nervous system.

Authors:  Charles K Abrams; Steven S Scherer
Journal:  Biochim Biophys Acta       Date:  2011-08-16

5.  Post-translational modifications of connexin26 revealed by mass spectrometry.

Authors:  Darren Locke; Shengjie Bian; Hong Li; Andrew L Harris
Journal:  Biochem J       Date:  2009-12-10       Impact factor: 3.857

6.  Functional requirement for a highly conserved charged residue at position 75 in the gap junction protein connexin 32.

Authors:  Charles K Abrams; Mahee Islam; Rola Mahmoud; Taekyung Kwon; Thaddeus A Bargiello; Mona M Freidin
Journal:  J Biol Chem       Date:  2012-12-03       Impact factor: 5.157

7.  Cx29 and Cx32, two connexins expressed by myelinating glia, do not interact and are functionally distinct.

Authors:  Meejin Ahn; Jonathan Lee; Andreas Gustafsson; Alan Enriquez; Eric Lancaster; Jai-Yoon Sul; Philip G Haydon; David L Paul; Yan Huang; Charles K Abrams; Steven S Scherer
Journal:  J Neurosci Res       Date:  2008-04       Impact factor: 4.164

8.  Properties of human connexin 31, which is implicated in hereditary dermatological disease and deafness.

Authors:  Charles K Abrams; Mona M Freidin; Vytas K Verselis; Thaddeus A Bargiello; David P Kelsell; Gabriele Richard; Michael V L Bennett; Feliksas F Bukauskas
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-20       Impact factor: 11.205

9.  Trifluoroethanol reveals helical propensity at analogous positions in cytoplasmic domains of three connexins.

Authors:  Alfredo G Fort; David C Spray
Journal:  Biopolymers       Date:  2009       Impact factor: 2.505

10.  Cataracts are caused by alterations of a critical N-terminal positive charge in connexin50.

Authors:  Bettina C Thomas; Peter J Minogue; Virginijus Valiunas; Giedrius Kanaporis; Peter R Brink; Viviana M Berthoud; Eric C Beyer
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-03-07       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.